AST

Activities: Pharmaceutical

Visit website

Profile

Trending Articles

  1. Eli Lilly Partners with NVIDIA to build pharma-focused AI supercomputer Lilly and NVIDIA have established a partnership to create a 1,000+ GPU AI supercomputer designed to transform drug discovery, clinical development and manufacturing
  2. Contract awarded to build Japan’s first cell-therapy smart factory Turner & Townsend and Hitachi Plant Service have secured a contract to build a smart cell-therapy manufacturing facility for Cellares
  3. High Tech Campus Eindhoven to build cleanroom for TNO’s 6-inch photonic chip pilot line HTCE has committed to constructing a new building and cleanroom infrastructure for photonic chip pilot line, supporting TNO’s scale-up efforts
  4. CCI vK and Kanomax Group form European partnership in particle measurement technology German-based CCI vK GmbH & Co KG has entered a strategic partnership with Kanomax Group to strengthen sales, service and technical support for particle measurement and...
  5. GMP Annex 1: Validation of disinfectants on cleanroom surfaces Published in August 2022, for implementation in August 2023, Karen Rossington from Contec looks at the revised version of EU GMP Annex 1 expanded and clarified the regulatory...

Upcoming event

CPhI Middle East

8–10 December 2024 | Conference | Riyadh, Saudi Arabia See all

Related Content

Containment

AST X CURIS: A new phase of decontamination

The Atmos™ Isolator features industry-leading automated decontamination technology from CURIS System, which uses a low-concentration application of Vapor Phase Hydrogen Peroxide (VPHP). The innovative 7000ei system integrates seamlessly with AST technology for a unified, single point of operation. The patented Rapid Vapor™ system with 7% CURoxide™ provides industry-leading decontamination cycle times and prioritizes production uptime and the life of your fill-finish equipment
Pharmaceutical

New AST white paper: Advancements in real-time IPC

One of the primary considerations in the production of liquid pharmaceuticals is the implementation of quality control measures during the filling and closing process
Recruitment

AST appoints new Chief Operations Officer to support global growth

Sterile technology manufacturer AST has appointed former IPS Head of Operations, Jacob Stephen
You need to be a subscriber to read this article.
Click here to find out more.
Design & Build

A question of quality: Implementing quality by design principles

Jason Rossi from AST discusses how a systematic approach, “Quality by Design”, is used to design and develop of drug product manufacturing environment that prioritises product quality and QRM principles
Design & Build

AST partners with Bora Pharmaceuticals to boost U.S. fill-finish capacity

GENiSYS C isolator system to enhance sterile drug product manufacturing in Baltimore
Pharmaceutical

AST celebrates 60 years of excellence in innovation and looks to the future of drug product manufacturing

This milestone celebration sets the stage for AST’s next phase of strategic growth, anchored by its revitalised mission, vision, and purpose statements
Containment

AST welcomes Jason Rossi as Principal CQV Engineer

Rossi brings over 29 years of expertise and leadership in aseptic fill-finish and in the design, construction, commissioning, and qualification of pharmaceutical manufacturing systems and facilities
Subscribe now